Preclinical combination of an EGFR inhibitor and a COX-2 inhibitor was effective. Advanced oral precancerous lesions were eliminated in three patients. Drug combination could be a new strategy to prevent head and neck cancers. PHILADELPHIA — A new drug combination shows promise in reducing the...
Posted to
News
by
AACR News
on
Tue, Feb 19 2013
Filed under:
Filed under: Press Releases, Research, Treatment, Cancer, Media Materials, AACR, American Association for Cancer Research, Clinical Cancer Research, journal, high-risk, squamous cell carcinoma, head and neck cancer, clinical research, precancer, combination, Dr. Dong Moon Shin, oral precancerous lesions
Tweet • Results based on lower-cost MRI screenings for high-risk, uninsured or under-insured women.• MRI screenings found more cancer cases in high-risk women than mammography.• Underserved women can benefit from follow-up with the...
Posted to
News
by
AACR News
on
Mon, Sep 19 2011
Filed under:
Filed under: Press Releases, Health insurance, Compliance, Mammography, MRI, Research, Breast Cancer, Conference, Cancer, Media Materials, AACR, cancer prevention, American Association for Cancer Research, prevention, minorities, women, Disparities, screening, cancer health disparities, meeting, magnetic resonance imaging, Diagnosis, The Science of Cancer Health Disparities, high-risk, breast navigation team, breast cancer screening, gynecology, Dr. Anne C. Ford, cost, underserved
Tweet • African ancestry linked to increased rates of high-risk disease.• Variants may be found in patients of any ethnic makeup. WASHINGTON, D.C. — Patients with a high degree of African ancestry had a greater incidence of high-risk neuroblastoma...
Posted to
News
by
AACR News
on
Mon, Sep 19 2011
Filed under:
Filed under: Press Releases, Pediatrics, Research, Treatment, children, Conference, Cancer, Media Materials, AACR, American Association for Cancer Research, genetics, minorities, Disparities, cancer health disparities, meeting, childhood cancer, The Science of Cancer Health Disparities, Dr. Navin R. Pinto, pediatric oncology, neuroblastoma, high-risk